The Clinical and Economic Benefits Associated With Novel Multi-Cancer Early Detection Tests: Conference Highlights from the 2022 ISPOR Annual Meeting
Advertisement
Advertisement
Trending on AJMC
1
Bills to Address Expiring ACA Subsidies Fail to Pass Senate
2
Clascoterone 5% Delivers Strong Phase 3 Results for Androgenetic Alopecia
3
Pirtobrutinib Outperforms Bendamustine-Rituximab in Frontline CLL/SLL
4
Real-World Safety Signals of Bimekizumab Emerge in New FAERS Analysis
5
